


Searching News Database: phosphate binding
HSMN NewsFeed - 26 Oct 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
HSMN NewsFeed - 28 Oct 2009
Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
HSMN NewsFeed - 6 Nov 2007
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
HSMN NewsFeed - 20 Nov 2006
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
HSMN NewsFeed - 20 Jul 2006
Fresenius Medical Care Receives Regulatory Approval for New Phosphate Binding Agent in Germany
Fresenius Medical Care Receives Regulatory Approval for New Phosphate Binding Agent in Germany
Additional items found! 8
Members Archive contains
8 additional stories matching:
phosphate binding
(Password required)
phosphate binding
(Password required)
